Sex steroid receptors in human lung diseases MK Verma, Y Miki, H Sasano The Journal of steroid biochemistry and molecular biology 127 (3-5), 216-222, 2011 | 54 | 2011 |
Aromatase in human lung carcinoma MK Verma, Y Miki, H Sasano Steroids 76 (8), 759-764, 2011 | 47 | 2011 |
Co-expression of estrogen receptor beta and aromatase in Japanese lung cancer patients: gender-dependent clinical outcome MK Verma, Y Miki, K Abe, S Nagasaki, H Niikawa, S Suzuki, T Kondo, ... Life sciences 91 (15-16), 800-808, 2012 | 43 | 2012 |
A next generation bivalent human Ad5 COVID-19 vaccine delivering both spike and nucleocapsid antigens elicits Th1 dominant CD4+, CD8+ T-cell and neutralizing antibody responses A Rice, M Verma, A Shin, L Zakin, P Sieling, S Tanaka, H Adisetiyo, J Taft, ... BioRxiv, 2020.07. 29.227595, 2020 | 36 | 2020 |
Intranasal plus subcutaneous prime vaccination with a dual antigen COVID-19 vaccine elicits T-cell and antibody responses in mice A Rice, M Verma, A Shin, L Zakin, P Sieling, S Tanaka, J Balint, K Dinkins, ... Scientific Reports 11 (1), 14917, 2021 | 30 | 2021 |
Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor MK Verma, Y Miki, K Abe, T Suzuki, H Niikawa, S Suzuki, T Kondo, ... Journal of Translational Medicine 11, 1-11, 2013 | 26 | 2013 |
A novel hemolytic complement-sufficient NSG mouse model supports studies of complement-mediated antitumor activity in vivo MK Verma, J Clemens, L Burzenski, SB Sampson, MA Brehm, DL Greiner, ... Journal of immunological methods 446, 47-53, 2017 | 23 | 2017 |
Humanized mice in translational immunology MA Brehm, R Bortell, M Verma, LD Shultz, DL Greiner Translational immunology: mechanisms and pharmacological approaches, 285-326, 2016 | 18 | 2016 |
Dual-antigen COVID-19 vaccine subcutaneous prime delivery with oral boosts protects NHP against SARS-CoV-2 challenge E Gabitzsch, JT Safrit, M Verma, A Rice, P Sieling, L Zakin, A Shin, ... Frontiers in Immunology, 3634, 2021 | 16 | 2021 |
Complete protection of nasal and lung airways against SARS-CoV-2 challenge by antibody plus Th1 dominant N-and S-specific T-cell responses to subcutaneous prime and thermally … E Gabitzsch, JT Safrit, M Verma, A Rice, P Sieling, L Zakin, A Shin, ... bioRxiv, 2020.12. 08.416297, 2020 | 16 | 2020 |
Cytoplasmic estrogen receptor β as a potential marker in human non-small cell lung carcinoma MK Verma, Y Miki, K Abe, H Niikawa, H Sasano Expert Opinion on Therapeutic Targets 16 (sup1), S91-S102, 2012 | 15 | 2012 |
Prime hAd5 spike+ nucleocapsid vaccination induces ten-fold increases in mean T-cell responses in phase 1 subjects that are sustained against spike variants P Sieling, T King, R Wong, A Nguyen, K Wnuk, E Gabitzsch, A Rice, ... medRxiv, 2021.04. 05.21254940, 2021 | 14 | 2021 |
Heterologous saRNA prime, DNA dual-antigen boost SARS-CoV-2 vaccination elicits robust cellular immunogenicity and cross-variant neutralizing antibodies A Rice, M Verma, E Voigt, P Battisti, S Beaver, S Reed, K Dinkins, S Mody, ... Frontiers in Immunology 13, 910136, 2022 | 7 | 2022 |
Anti covid-19 therapies using nucleocapsid and spike proteins A Rice, M Verma US Patent App. 17/405,393, 2022 | 7 | 2022 |
The Dual-Antigen Ad5 COVID-19 Vaccine Delivered as an Intranasal Plus Subcutaneous Prime Elicits Th1 Dominant T-Cell and Humoral Responses in CD-1 Mice A Rice, M Verma, A Shin, L Zakin, P Sieling, S Tanaka, J Balint, K Dinkins, ... bioRxiv, 2021.03. 22.436476, 2021 | 5 | 2021 |
Single Prime Had5 Spike (s)+ Nucleocapsid (N) Dual Antigen Vaccination of Healthy Volunteers Induces a Ten-Fold Increase in Mean s-and N-T-Cell Responses Equivalent to T-Cell … P Sieling, T King, R Wong, A Nguyen, K Wnuk, ER Gabitzsch, A Rice, ... | 5 | 2021 |
Genetically modified non-human animals and methods relating to complement dependent cytotoxicity LD Shultz, MK Verma, DL Greiner, MA Brehm US Patent 10,701,911, 2020 | 1 | 2020 |
Endocrine therapy after aromatase inhibitor therapy in breast cancer MK Verma, Y Miki, H Sasano Expert Review of Endocrinology & Metabolism 6 (3), 309-312, 2011 | 1 | 2011 |
SmRNA PRIME S+ N DNA BOOST VACCINATION ELICITS ROBUST IMMUNE RESPONSES in MICE A Rice, M Verma, E Voigt, P Battisti, S Beaver, K Dinkins, S Mody, ... Topics in Antiviral Medicine, 92-92, 2022 | | 2022 |
Heterologous Vaccination with SARS-CoV-2 Spike saRNA Prime followed by DNA Dual-Antigen Boost Induces Robust Antibody and T-Cell Immunogenicity against both Wild Type and Delta … A Rice, M Verma, E Voigt, P Battisti, S Beaver, S Reed, K Dinkins, S Mody, ... bioRxiv, 2021.11. 29.470440, 2021 | | 2021 |